Trials for neurodegenerative diseases: time to innovate

被引：7
|
作者：
Mehta, Arpan R.
Chataway, Jeremy
Pal, Suvankar
Parmar, Mahesh K. B.
Chandran, Siddharthan
机构：
来源：
LANCET NEUROLOGY | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1016/S1474-4422(21)00388-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：984 / 984
页数：1
相关论文
共 50 条
  • [31] Secondary and tertiary endpoints in clinical trials for neuromuscular/neurodegenerative diseases: a descriptive analysis
    Robinson, C.
    Heath, N.
    Aiello, A.
    Devecseri, Z.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E343 - E343
  • [32] Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases
    Hellmers, Natalie
    Obeng-Aduasare, Yaa
    de Melo-Martin, Inmaculada
    Henchcliffe, Claire
    [J]. NEURAL REGENERATION RESEARCH, 2016, 11 (01) : 83 - 85
  • [33] Neurodegenerative Diseases
    Volk, Alexander E.
    Kubisch, Christian
    [J]. MEDIZINISCHE GENETIK, 2018, 30 (02): : 229 - 230
  • [34] Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future
    Lang, Anthony E.
    [J]. NATURE MEDICINE, 2010, 16 (11) : 1223 - 1226
  • [35] Olfactory neurodegenerative pathology in neurodegenerative diseases
    Jellinger, K. A.
    Walker, L.
    Attems, J.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 : 35 - 35
  • [36] Evaluation of apathy using reaction time task in neurodegenerative diseases
    David, R.
    Colazzo, G.
    Siccardi, L.
    Forcellino, L.
    Vada, A.
    Louchart, S.
    Serrati, C.
    Piva, M.
    Robert, P. H.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S193 - S193
  • [37] Safety of masitinib in patients with neurodegenerative diseases: a meta-analysis of randomized controlled trials
    Hamad, Abdullah Ashraf
    Amer, Basma Ehab
    [J]. NEUROLOGICAL SCIENCES, 2024, 45 (07) : 3503 - 3507
  • [38] Time to innovate service delivery?
    Nelson-Pratt, Adrian
    [J]. VETERINARY RECORD, 2018, 183 (05) : 166 - 166
  • [39] Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases
    Haston, Kelly M.
    Finkbeiner, Steven
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56, 2016, 56 : 489 - 510
  • [40] Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials
    Avallone, Rossella
    Vitale, Giovanni
    Bertolotti, Marco
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
12345